News Center

Zhejiang Doer Biologics Announces License Agreement with BioNTech

2023/07/11

Read more

Many mainstream media reported the collaboration between Zhejiang Doer Biologics and MSD

2022/12/19

Read more

Reported by PR Newswire published

2022/12/17

Read more

Zhejiang Doer Biologics Announces Clinical Trial Collaboration with MSD

2022/12/16

Read more

Doer Biologics signs licensing agreement with Lonza to develop multi-specific biotherapeutics using XS Pichia

2022/12/09

Read more

Doer Biologics interview by Biopharma Reporter published

2021/12/16

Read more

PR post reshared by Bioprocess international

2021/12/14

Read more

Doer Biologics CEO invited as speaker at BIT 2021

2021/04/10

Read more

Doer Biologics won the honor of the first "Qiantang Leading Talent Team" in the new district

2020/12/17

Read more

Doer Biologics Received nearly 100 millions of RMB in A+ round of financing to promote the research of multispecific innovative biologics

2020/11/02

Read more